A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
International Journal of Pharmaceutical Technology and Biotechnology 39 *Corresponding Author: RECENT TRENDS IN ETIOLOGY AND MANAGEMENT OF XEROSTOMIA: A REVIEW
unpublished
The delivery of drug substance through the mucosa (oral) presents a great opportunity but also poses continuing challenges. Xerostomia, the excessive dryness of mouth, and reduction in the saliva secretion poses a debilitating condition for majority of patients. Evaluation of xerostomia starts with a careful and complete examination of mouth. Numerous treatments are available for the management of xerostomia including salivary stimulants, saliva substitutes, topical agents and sialogogues for
fatcat:w52whhrllvddxnlwybblxgifwe